Chrysalis BioTherapeutics Selected to Present at Respiratory Innovation Summit
06 May 2024 //
BUSINESSWIRE
Chrysalis Receives FDA Approval to Initiate Trials with Chrysalin™ (TP508)
26 Sep 2023 //
BUSINESSWIRE
Intouch Group Launches Pro-Bono Alliance with The Chrysalis Initiative
05 Oct 2021 //
PRNEWSWIRE
Chrysalis BioTherapeutics Receives $10.4 Million From BARDA
01 Dec 2020 //
BUSINESSWIRE
Chrysalis Receives $10.4 M From BARDA to Continue Development of TP508
01 Dec 2020 //
BUSINESSWIRE
Chrysalis Receives Additional Funding from the National Institutes of Health
12 Aug 2020 //
BUSINESSWIRE